Off-Label Use of Dupilumab in Children With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Off-Label Use of Dupilumab for Pediatric Patients With Atopic Dermatitis: A Multicenter Retrospective Review
J Am Acad Dermatol 2019 Oct 10;[EPub Ahead of Print], S Igelman, AO Kurta, U Sheikh, A McWilliams, E Armbrecht, SR Jackson Cullison, DW Kress, A Smith, L Castelo-Soccio, J Treat, WD Boothe, LZ Diaz, ML Levy, A Patel, LW Lee, MC Fraile-Alonso, RJ Antaya, S Shah, N Kittler, L Arkin, E SiegfriedFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.